224 related articles for article (PubMed ID: 23316980)
1. Predictive biomarkers for Barrett's esophagus: so near and yet so far.
Timmer MR; Sun G; Gorospe EC; Leggett CL; Lutzke L; Krishnadath KK; Wang KK
Dis Esophagus; 2013 Aug; 26(6):574-81. PubMed ID: 23316980
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers in Barrett's esophagus and esophageal adenocarcinoma: predictors of progression and prognosis.
Ong CA; Lao-Sirieix P; Fitzgerald RC
World J Gastroenterol; 2010 Dec; 16(45):5669-81. PubMed ID: 21128316
[TBL] [Abstract][Full Text] [Related]
3. Surveillance in Barrett's esophagus: a failed premise.
Inadomi JM
Keio J Med; 2009 Mar; 58(1):12-8. PubMed ID: 19398879
[TBL] [Abstract][Full Text] [Related]
4. A genomic biomarker-based model for cancer risk stratification of non-dysplastic Barrett's esophagus patients after extended follow up; results from Dutch surveillance cohorts.
Hoefnagel SJM; Mostafavi N; Timmer MR; Lau CT; Meijer SL; Wang KK; Krishnadath KK
PLoS One; 2020; 15(4):e0231419. PubMed ID: 32282835
[TBL] [Abstract][Full Text] [Related]
5. Advances in Biomarkers for Risk Stratification in Barrett's Esophagus.
Souza RF; Spechler SJ
Gastrointest Endosc Clin N Am; 2021 Jan; 31(1):105-115. PubMed ID: 33213790
[TBL] [Abstract][Full Text] [Related]
6. The diagnosis and management of Barrett's esophagus.
DeMeester SR; DeMeester TR
Adv Surg; 1999; 33():29-68. PubMed ID: 10572561
[TBL] [Abstract][Full Text] [Related]
7. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma.
Weston AP; Badr AS; Hassanein RS
Am J Gastroenterol; 1999 Dec; 94(12):3413-9. PubMed ID: 10606296
[TBL] [Abstract][Full Text] [Related]
8. Barrett's Esophagus and Esophageal Carcinoma: Can Biomarkers Guide Clinical Practice?
Konda VJA; Souza RF
Curr Gastroenterol Rep; 2019 Mar; 21(4):14. PubMed ID: 30868278
[TBL] [Abstract][Full Text] [Related]
9. Surveillance in Barrett's esophagus: an audit of practice.
Ajumobi A; Bahjri K; Jackson C; Griffin R
Dig Dis Sci; 2010 Jun; 55(6):1615-21. PubMed ID: 19669878
[TBL] [Abstract][Full Text] [Related]
10. What Makes an Expert Barrett's Histopathologist?
van der Wel MJ; Jansen M; Vieth M; Meijer SL
Adv Exp Med Biol; 2016; 908():137-59. PubMed ID: 27573771
[TBL] [Abstract][Full Text] [Related]
11. Molecular biomarkers added to image-enhanced endoscopic imaging: will they further improve diagnostic accuracy?
Krishnamoorthi R; Iyer PG
Best Pract Res Clin Gastroenterol; 2015 Aug; 29(4):561-73. PubMed ID: 26381302
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers of esophageal adenocarcinoma and Barrett's esophagus.
McManus DT; Olaru A; Meltzer SJ
Cancer Res; 2004 Mar; 64(5):1561-9. PubMed ID: 14996709
[TBL] [Abstract][Full Text] [Related]
13. Role of epigenetic alterations in the pathogenesis of Barrett's esophagus and esophageal adenocarcinoma.
Agarwal A; Polineni R; Hussein Z; Vigoda I; Bhagat TD; Bhattacharyya S; Maitra A; Verma A
Int J Clin Exp Pathol; 2012; 5(5):382-96. PubMed ID: 22808291
[TBL] [Abstract][Full Text] [Related]
14. Barrett's esophagus and Barrett's-related dysplasia.
Goldblum JR
Mod Pathol; 2003 Apr; 16(4):316-24. PubMed ID: 12692197
[TBL] [Abstract][Full Text] [Related]
15. A Tissue Systems Pathology Assay for High-Risk Barrett's Esophagus.
Critchley-Thorne RJ; Duits LC; Prichard JW; Davison JM; Jobe BA; Campbell BB; Zhang Y; Repa KA; Reese LM; Li J; Diehl DL; Jhala NC; Ginsberg G; DeMarshall M; Foxwell T; Zaidi AH; Lansing Taylor D; Rustgi AK; Bergman JJ; Falk GW
Cancer Epidemiol Biomarkers Prev; 2016 Jun; 25(6):958-68. PubMed ID: 27197290
[TBL] [Abstract][Full Text] [Related]
16. Barrett's Esophagus and Esophageal Adenocarcinoma Biomarkers.
Grady WM; Yu M; Markowitz SD; Chak A
Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2486-2494. PubMed ID: 33093162
[TBL] [Abstract][Full Text] [Related]
17. Screening and surveillance for Barrett's esophagus: current issues and future directions.
Choi SE; Hur C
Curr Opin Gastroenterol; 2012 Jul; 28(4):377-81. PubMed ID: 22508325
[TBL] [Abstract][Full Text] [Related]
18. Barrett's esophagus: Macroscopic markers and the prediction of dysplasia and adenocarcinoma.
Hillman LC; Chiragakis L; Clarke AC; Kaushik SP; Kaye GL
J Gastroenterol Hepatol; 2003 May; 18(5):526-33. PubMed ID: 12702044
[TBL] [Abstract][Full Text] [Related]
19. Large intra- and inter-individual variability of genes expression levels limits potential predictive value of molecular diagnosis of dysplasia in Barrett's esophagus.
Hennig EE; Mikula M; Orlowska J; Jarosz D; Bielasik A; Regula J; Ostrowski J
J Mol Med (Berl); 2008 Feb; 86(2):233-42. PubMed ID: 17952395
[TBL] [Abstract][Full Text] [Related]
20. Fluorescence in situ hybridization mapping of esophagectomy specimens from patients with Barrett's esophagus with high-grade dysplasia or adenocarcinoma.
Brankley SM; Fritcher EG; Smyrk TC; Keeney ME; Campion MB; Voss JS; Clayton AC; Wang KK; Lutzke LS; Kipp BR; Halling KC
Hum Pathol; 2012 Feb; 43(2):172-9. PubMed ID: 21820152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
